Phone (336) 292-1510
Fax (336) 292-0679

Receive our eNewsletter

  Home  
  Our Team  
  Patient Info  
  Services  

News for Healthier Living

Immunotherapy May Boost KRAS-Targeted Therapy in Pancreatic Cancer

Adding immunotherapy to new KRAS inhibitors boosted responses in preclinical models, setting the stage for future trials of the combination strategy. The study was published in Cancer Discovery by researchers from the Perelman School of Medicine at the University of Pennsylvania and Penn Medicine's Abramson Cancer Center.

March 14, 2025


March 14 2025

March 13 2025

March 12 2025

March 11 2025

March 10 2025

March 9 2025

March 8 2025

March 7 2025

March 6 2025

March 5 2025

March 4 2025

March 3 2025

March 2 2025